Revitalist’s Kathryn Walker On Psychedelics & Their Potential To Upend Traditional Medicine Dec 2, 2021
Tryp Therapeutics Receives Confirmation from FDA to Proceed with Phase 2a Study in Fibromyalgia Dec 2, 2021
Braxia Scientific Wants To Offer Ketamine Treatments In ‘Less Restrictive’ Environments. Will It Be Safe? Dec 1, 2021
First-ever Human Data on SSRI – Psilocybin Interactive Effects Published by MindMed and Liechti Lab Nov 30, 2021
Pharmadrug Announces Successful Completion of Pre-IND Meeting with FDA Regarding Proposed Development of Its… Nov 30, 2021
MindMed and Liechti Lab publish first human data on the interacting effects of an SSRI and psilocybin Nov 30, 2021
